mHealthSpot is a media partner of the following events:
Cell and Gene Therapy Summit
Cell and gene therapies will reshape healthcare – but when? Join industry leaders and healthcare stakeholders in discussing barriers to mainstream advanced therapies and how to enhance patient access.
With advances in technology and many innovative treatments on the horizon, cell and gene therapies can reshape healthcare, giving hope to patients who previously had no therapeutic options. But when will their potential be fully realised?
Under the stewardship of The Economist’s editorial team, this event will convene industry leaders and healthcare stakeholders to debate the challenges of introducing advanced therapies into the mainstream. It will discuss changes in regulatory landscapes, delivery models, structuring clinical trials and gathering real-world evidence that can improve patient access while ensuring companies maintain a competitive edge.
Register today, seats are limited.
Returning to Boston, Massachusetts, this July for a 4th year, the mRNA-Based Therapeutics Summit’s 2024 agenda cements its position as the industry’s most comprehensive end-to-end mRNA meeting.
Showcasing the mRNA field’s latest advancements, hear from 65+ world-class speakers (including the likes of the FDA, EMA, CureVac, BioNTech, Sanofi and Moderna) across three days jam-packed with content.
Join over 400 of your mRNA peers for industry-led sessions spanning proof-of-concept studies, platform development, clinical updates, manufacturing strategies and regulatory insights across 4 tracks of content, catering to Discovery, Translation, Clinical Development and Chemistry, Manufacturing & Controls